Sandbox: sadaf: Difference between revisions
Jump to navigation
Jump to search
| Line 455: | Line 455: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" + | | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Vesicoureteral reflux]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| Line 479: | Line 479: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Hydronephrosis | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Hydronephrosis]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| Line 600: | Line 600: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |IgA nephropathy | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[IgA nephropathy]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| Line 624: | Line 624: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Renal transplant rejection | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Kidney transplantation|Renal transplant rejection]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| Line 649: | Line 649: | ||
|- | |- | ||
! rowspan="8" align="center" style="background:#DCDCDC;" + |[[Systemic disease]] | ! rowspan="8" align="center" style="background:#DCDCDC;" + |[[Systemic disease]] | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Malignant hypertension | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Malignant hypertension]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| Line 673: | Line 673: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Diabetic nephropathy | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Diabetic nephropathy]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| Line 697: | Line 697: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Sickle cell disease | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Sickle-cell disease|Sickle cell disease]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| Line 721: | Line 721: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Sarcoidosis | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Sarcoidosis]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| Line 769: | Line 769: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Sjögren’s syndrome | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Sjögren's syndrome|Sjögren’s syndrome]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| Line 842: | Line 842: | ||
|- | |- | ||
! rowspan="5" align="center" style="background:#DCDCDC;" + |Medication/toxin | ! rowspan="5" align="center" style="background:#DCDCDC;" + |Medication/toxin | ||
! colspan="2" align="center" style="background:#DCDCDC;" + | | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Analgesic nephropathy]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| Line 866: | Line 866: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Contrast-induced nephropathy | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Contrast induced nephropathy|Contrast-induced nephropathy]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| Line 890: | Line 890: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Glucocorticoids | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Glucocorticoids]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| Line 914: | Line 914: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Toluene | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Toluene]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| Line 938: | Line 938: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Lead poisoning | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Lead poisoning]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Revision as of 16:45, 29 May 2018
Pyuria Differential Diagnosis
Differentiating the diseases that can cause pyuria:[1]
| Category | Disease | Clinical manifestations | Para−clinical findings | Gold standard for diagnosis | Associated findings | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Symptoms | Physical examination | ||||||||||||||||||||||||
| Lab Findings | Imaging | ||||||||||||||||||||||||
| Pain | Fever | N/V | Urinary symptoms | BP | Edema | Other | CBC | Electrolytes | Urinalysis | Ultrasound | CT scan | Other | |||||||||||||
| Dysuria | Frequency | Urgency | Gross hematuria | Cell | Cast | Bacteriuria | Culture | Other | |||||||||||||||||
| Infectious diseases | UTI | Bacterial | Asymptomatic bacteriuria | − | − | − | − | − | − | − | Nl | − | − | Nl | Nl | − | − | + | − | − | − | − | − | Urinalysis |
|
| Cystitis | − | − | − | + | + | + | − | Nl | − | − | Nl | Nl | ↑ | − | + | + | Nitrite + | − | − | − | Urinalysis | ||||
| Pyelonephritis | + | + | + | + | + | + | − | Nl | − | − | WBC ↑ | Nl | ↑ | WBC cast | + | + | Nitrite + | − | − | − | Clinical manifestation + urinalysis | ||||
| Viral | |||||||||||||||||||||||||
| Tuberculosis | |||||||||||||||||||||||||
| Fungal | |||||||||||||||||||||||||
| Urethritis | Chlamydia | ||||||||||||||||||||||||
| Gonococcus | |||||||||||||||||||||||||
| Prostatitis | |||||||||||||||||||||||||
| Balanitis | |||||||||||||||||||||||||
| PID | |||||||||||||||||||||||||
| Appendicitis | |||||||||||||||||||||||||
| Non−infectious diseases | Urinary tract disorders | Urinary catheterization | |||||||||||||||||||||||
| Urinary tract stone | |||||||||||||||||||||||||
| Urinary tract neoplasm | |||||||||||||||||||||||||
| Urinary fistula | |||||||||||||||||||||||||
| Interstitial cystitis | |||||||||||||||||||||||||
| Vesicoureteral reflux | |||||||||||||||||||||||||
| Hydronephrosis | |||||||||||||||||||||||||
| Renal diseases | Polycystic kidney disease | ||||||||||||||||||||||||
| Renal vein thrombosis | |||||||||||||||||||||||||
| Interstitial nephritis | |||||||||||||||||||||||||
| Papillary necrosis | |||||||||||||||||||||||||
| IgA nephropathy | |||||||||||||||||||||||||
| Renal transplant rejection | |||||||||||||||||||||||||
| Systemic disease | Malignant hypertension | ||||||||||||||||||||||||
| Diabetic nephropathy | |||||||||||||||||||||||||
| Sickle cell disease | |||||||||||||||||||||||||
| Sarcoidosis | |||||||||||||||||||||||||
| Systemic lupus erythematosus | |||||||||||||||||||||||||
| Sjögren’s syndrome | |||||||||||||||||||||||||
| Kawasaki's disease | |||||||||||||||||||||||||
| Graft versus host disease (GVHD) | |||||||||||||||||||||||||
| Medication/toxin | Analgesic nephropathy | ||||||||||||||||||||||||
| Contrast-induced nephropathy | |||||||||||||||||||||||||
| Glucocorticoids | |||||||||||||||||||||||||
| Toluene | |||||||||||||||||||||||||
| Lead poisoning | |||||||||||||||||||||||||
| Category | Disease | Pain | Fever | N/V | Dysuria | Frequency | Urgency | Gross hematuria | BP | Edema | Other | CBC | Electrolytes | Cell | Cast | Bacteriuria | Culture | Other | Ultrasound | CT scan | Other | Gold standard for diagnosis | Associated findings | ||
- ↑ Wise, Gilbert J.; Longo, Dan L.; Schlegel, Peter N. (2015). "Sterile Pyuria". New England Journal of Medicine. 372 (11): 1048–1054. doi:10.1056/NEJMra1410052. ISSN 0028-4793.